Recent News

• 05.27.2026 - Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
• 05.15.2026 - Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
• 05.08.2026 - Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
• 04.15.2026 - Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights

Recent Filings

• 05.27.2026 - 8-K Current report
• 05.27.2026 - EX-99.1 EX-99.1
• 05.26.2026 - 8-K Current report
• 05.22.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.19.2026 - PRE 14A Other preliminary proxy statements
• 05.15.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 05.15.2026 - EX-99.1 EX-99.1
• 05.15.2026 - EFFECT Notice of Effectiveness
• 05.15.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2026 - 8-K Current report